Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.23 - $319.0 $2,921 - $4.05 Million
-12,703 Reduced 33.13%
25,635 $8,000
Q2 2022

Aug 15, 2022

BUY
$0.19 - $0.45 $3,214 - $7,612
16,917 Added 78.97%
38,338 $9,000
Q1 2022

May 12, 2022

BUY
$0.36 - $0.77 $7,711 - $16,494
21,421 New
21,421 $8,000
Q4 2021

Feb 14, 2022

SELL
$0.69 - $1.73 $34 - $86
-50 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$1.38 - $2.15 $69 - $107
50 New
50 $0

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $353M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.